EOSINOPHILIC granuloma of the lung without associated ... Bell, for remarks on pathology of the lesions, Dr. Frank Martin, for his co-operation in the preparation of the x-ray films, Dr. William ...

In patients with eosinophilic esophagitis, etrasimod led to sustained histologic and endoscopic improvement over a year, with ...

The global eosinophilic esophagitis market is on the cusp of a remarkable transformation, according to the latest comprehensive analysis released by Future Market Insights (FMI). The report forecasts ...

NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

Eosinophilic esophagitis (EoE) is a chronic disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. It’s related to chronic allergies to either food ...

Telisotuzumab vedotin-tllv is now approved for advanced non-squamous NSCLC with high c-Met overexpression after prior treatment. The drug targets c-MET expression, impacting approximately 25% of ...

Eosinophilic oesophagitis is a chronic, allergen-induced, type 2-mediated inflammation and, in most cases, a relapsing disease of the oesophagus. It is characterised by a wide range of symptoms of ...

underlying differences between the European and US scientific statements on this topic. We explain the role of histology that defines subtypes of myocarditis and its prognostic and therapeutic ...

Epithelial gene expression of type 2 inflammatory markers, IL-13, and mast cell-related genes was significantly higher in the eosinophilic group, while type 1 and type 17 signatures were comparable ...

EOSINOPHILIC esophagitis (EoE) is a chronic, immune-mediated condition marked by esophageal inflammation and symptoms such as difficulty swallowing, chest pain, and heartburn. Surprisingly, recent ...